• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝细胞癌外科治疗的当前及未来挑战:综述

Current and future challenges in the surgical treatment of hepatocellular carcinoma: a review.

作者信息

Tsoulfas Georgios, Agorastou Polyxeni, Tooulias Andreas, Marakis Georgios N

机构信息

1 Department of Surgery, Aristoteleion University of Thessaloniki, Thessaloniki, Greece.

出版信息

Int Surg. 2014 Nov-Dec;99(6):779-86. doi: 10.9738/INTSURG-D-13-00122.1.

DOI:10.9738/INTSURG-D-13-00122.1
PMID:25437587
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4254240/
Abstract

Challenges in the treatment of hepatocellular carcinoma Hepatocellular carcinoma (HCC) represents one of the most frequent types of cancer worldwide. Surgery, although only a part of the armamentarium against HCC, represents the cornerstone in the management of this aggressive disease. This article will review the current and future challenges in the surgical management of HCC, with a special emphasis on the following areas: (1) the evolution of staging of the disease and the importance of the biological nature and behavior of HCC, (2) the effort to increase resectability, (3) technical innovations and the role of image-guided surgery, and, finally, (4) the role of liver transplantation in the continuum of care for these patients. Although by no means an exhaustive list, the issues mentioned above represent some of the most promising prospects for significant progress in the management of HCC.

摘要

肝细胞癌治疗中的挑战 肝细胞癌(HCC)是全球最常见的癌症类型之一。手术虽是对抗HCC的手段之一,但却是这种侵袭性疾病管理的基石。本文将回顾HCC外科治疗当前和未来面临的挑战,特别强调以下几个方面:(1)疾病分期的演变以及HCC生物学特性和行为的重要性,(2)提高可切除性的努力,(3)技术创新及影像引导手术的作用,最后是(4)肝移植在这些患者连续治疗中的作用。虽然上述内容绝非详尽无遗,但所提及的问题代表了HCC管理取得重大进展的一些最有前景的方向。

相似文献

1
Current and future challenges in the surgical treatment of hepatocellular carcinoma: a review.肝细胞癌外科治疗的当前及未来挑战:综述
Int Surg. 2014 Nov-Dec;99(6):779-86. doi: 10.9738/INTSURG-D-13-00122.1.
2
Technical Aspects of Orthotopic Liver Transplantation for Hepatocellular Carcinoma.肝细胞癌原位肝移植的技术要点
Surg Clin North Am. 2016 Apr;96(2):269-81. doi: 10.1016/j.suc.2015.11.004. Epub 2016 Feb 16.
3
Hepatocellular carcinoma: current management and perspectives for the future.肝细胞癌:当前的治疗管理与未来展望。
Ann Surg. 2011 Mar;253(3):453-69. doi: 10.1097/SLA.0b013e31820d944f.
4
Surgical treatment for liver cancer. Current issues.肝癌的外科治疗。当前问题。
Dig Surg. 2007;24(2):120-5. doi: 10.1159/000101899. Epub 2007 Apr 19.
5
Surgical resection and liver transplantation for hepatocellular carcinoma.手术切除和肝移植治疗肝细胞癌。
Clin Liver Dis. 2015 May;19(2):381-99. doi: 10.1016/j.cld.2015.01.007. Epub 2015 Mar 2.
6
Image-guided treatment for liver cancer.肝癌的图像引导治疗。
Radiol Technol. 2010 Nov-Dec;82(2):161VI-178VI.
7
Multidisciplinary management of hepatocellular carcinoma.肝细胞癌的多学科管理
Recent Results Cancer Res. 2013;190:247-59. doi: 10.1007/978-3-642-16037-0_16.
8
Surgical treatment for hepatocellular carcinoma.肝细胞癌的外科治疗
Saudi J Gastroenterol. 2015 Jan-Feb;21(1):11-7. doi: 10.4103/1319-3767.151216.
9
Surgery and transplantation for hepatocellular cancer.肝细胞癌的手术与移植治疗
Liver Transpl. 2000 Nov;6(6 Suppl 2):S16-22. doi: 10.1053/jlts.2000.19010.
10
Hepatocellular carcinoma: a comprehensive overview of surgical therapy.肝细胞癌:手术治疗的全面概述
J Surg Oncol. 2014 Nov;110(6):712-9. doi: 10.1002/jso.23673. Epub 2014 Jun 4.

引用本文的文献

1
Efficacy and safety of neoadjuvant therapy for hepatocellular carcinoma with portal vein thrombosis: A meta‑analysis.门静脉血栓形成的肝细胞癌新辅助治疗的疗效与安全性:一项荟萃分析。
Oncol Lett. 2025 Jan 7;29(3):122. doi: 10.3892/ol.2025.14868. eCollection 2025 Mar.
2
PRR34-AS1 promotes exosome secretion of VEGF and TGF-β via recruiting DDX3X to stabilize Rab27a mRNA in hepatocellular carcinoma.PRR34-AS1 通过招募 DDX3X 稳定 Rab27a mRNA 促进肝癌细胞外泌体分泌 VEGF 和 TGF-β。
J Transl Med. 2022 Oct 27;20(1):491. doi: 10.1186/s12967-022-03628-9.
3
Artificial intelligence in the detection, characterisation and prediction of hepatocellular carcinoma: a narrative review.人工智能在肝细胞癌检测、特征描述及预测中的应用:一项叙述性综述
Transl Gastroenterol Hepatol. 2022 Oct 25;7:41. doi: 10.21037/tgh-20-242. eCollection 2022.
4
A Concise Review on Current Trends in Imaging and Surgical Management of Hepatocellular Carcinoma.肝细胞癌影像与外科治疗当前趋势的简要综述
Cureus. 2020 Jul 14;12(7):e9191. doi: 10.7759/cureus.9191.
5
Idelalisib promotes Bim-dependent apoptosis through AKT/FoxO3a in hepatocellular carcinoma.依鲁替尼通过 AKT/FoxO3a 促进肝癌细胞中的 Bim 依赖性细胞凋亡。
Cell Death Dis. 2018 Sep 17;9(10):935. doi: 10.1038/s41419-018-0960-8.
6
Apatinib-loaded lipid nanobubbles combined with ultrasound-targeted nanobubble destruction for synergistic treatment of HepG2 cells in vitro.载阿帕替尼脂质纳米泡联合超声靶向微泡破坏技术在体外协同治疗HepG2细胞
Onco Targets Ther. 2018 Aug 10;11:4785-4795. doi: 10.2147/OTT.S170786. eCollection 2018.
7
Synergistic effect of nutlin-3 combined with aspirin in hepatocellular carcinoma HepG2 cells through activation of Bcl-2/Bax signaling pathway.联合应用 nutlin-3 和阿司匹林通过激活 Bcl-2/Bax 信号通路对肝癌 HepG2 细胞的协同作用。
Mol Med Rep. 2018 Mar;17(3):3735-3743. doi: 10.3892/mmr.2017.8346. Epub 2017 Dec 22.
8
Relationship between ADH2 Arg47His variation and hepatocellular carcinoma susceptibility: a meta analysis.乙醇脱氢酶2基因Arg47His变异与肝细胞癌易感性的关系:一项荟萃分析
Int J Clin Exp Med. 2015 Jun 15;8(6):9543-8. eCollection 2015.

本文引用的文献

1
Analysis of the efficacy of portal vein embolization for patients with extensive liver malignancy and very low future liver remnant volume, including a comparison with the associating liver partition with portal vein ligation for staged hepatectomy approach.广泛肝脏恶性肿瘤且未来残余肝脏体积非常低的患者行门静脉栓塞术的疗效分析,包括与联合肝脏离断和门静脉结扎的分期肝切除术的比较。
J Am Coll Surg. 2013 Jul;217(1):126-33; discussion 133-4. doi: 10.1016/j.jamcollsurg.2013.03.004. Epub 2013 Apr 28.
2
In situ liver transection with portal vein ligation for rapid growth of the future liver remnant in two-stage liver resection.分期肝切除中门静脉结扎的原位肝切除术促进剩余肝脏的快速再生。
Br J Surg. 2013 Feb;100(3):388-94. doi: 10.1002/bjs.8955. Epub 2012 Nov 2.
3
How to avoid postoperative liver failure: a novel method.如何避免术后肝衰竭:一种新方法。
World J Surg. 2012 Jan;36(1):125-8. doi: 10.1007/s00268-011-1331-0.
4
Systematic review of outcome of downstaging hepatocellular cancer before liver transplantation in patients outside the Milan criteria.米兰标准以外的肝癌患者肝移植前降期治疗的结局的系统评价。
Br J Surg. 2011 Sep;98(9):1201-8. doi: 10.1002/bjs.7561. Epub 2011 May 27.
5
Identifying targets of miR-143 using a SILAC-based proteomic approach.使用基于稳定同位素标记氨基酸的细胞培养技术(SILAC)的蛋白质组学方法鉴定miR-143的靶标。
Mol Biosyst. 2010 Oct;6(10):1873-82. doi: 10.1039/c004401f. Epub 2010 Jun 14.
6
The challenges of liver transplantation for hepatocellular carcinoma on cirrhosis.肝硬化肝细胞癌肝移植的挑战。
Transpl Int. 2010 Jul;23(7):712-22. doi: 10.1111/j.1432-2277.2010.01111.x. Epub 2010 May 14.
7
Report of a national conference on liver allocation in patients with hepatocellular carcinoma in the United States.美国肝癌患者肝脏分配问题全国会议报告。
Liver Transpl. 2010 Mar;16(3):262-78. doi: 10.1002/lt.21999.
8
Hepatocellular carcinoma: new options for image-guided ablation.肝细胞癌:影像引导下消融治疗的新选择。
J Hepatobiliary Pancreat Sci. 2010 Jul;17(4):399-403. doi: 10.1007/s00534-009-0233-0. Epub 2009 Dec 1.
9
How to operate a liver tumor you cannot see.如何对一个你看不见的肝脏肿瘤进行手术操作。 (原句表述不太准确,推测这里“operate”可能是“operate on”即“对……做手术”的意思,按此理解翻译)
Langenbecks Arch Surg. 2009 May;394(3):489-94. doi: 10.1007/s00423-009-0469-9. Epub 2009 Mar 12.
10
Techniques for liver parenchymal transection in liver resection.肝切除术中肝实质离断技术。
Cochrane Database Syst Rev. 2009 Jan 21;2009(1):CD006880. doi: 10.1002/14651858.CD006880.pub2.